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Abstract 
Skin and soft tissue infections (SSTIs) occur at higher rates within correctional facilities due to 
the increased risks that are inherent in this population. These infections present at various stages, 
requiring different treatment modalities and sometimes require complex treatment. Prompt and 
accurate recognition of SSTIs is crucial in selecting appropriate treatment to decrease the 
possibility of treatment failure. Literature shows a correlation between diagnosis delay and 
increased time and overall cost of care related to delayed diagnosis of SSTIs. These findings 
support the implementation of an evidence-based project which aims to determine whether the 
utilization of an algorithm for SSTIs can be amplified through increased accessibility. 
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Skin and Soft Tissue Infections: Improving Treatments for the Incarcerated Population 
 Skin and soft tissue infections (SSTIs) are a common yet potentially life-threatening 
condition. They are difficult to identify and have the potential to be costly to treat or have poor 
long-term outcomes if misdiagnosed. In correctional health care facilities, the rate of treatment 
failure and recurrence directly causes an increase to overall costs to the health care system, 
making this issue important to examine. Populations at greatest risk for SSTIs include the 
incarcerated population, who have multiple risk factors which lead to the development of these 
infections. When pathogenic organisms enter the protective barrier provided by the skin, 
infections can occur which may or may not be self-limiting. Tissue damage is evident when the 
area presents with warmth, edema, erythema, and often pain (Aly, 1996). SSTIs often present in 
this manner and are categorized into two groups, purulent and non-purulent and then 
subcategorized depending on level of severity as mild, moderate, or severe. Treatments for 
purulent and non-purulent infections depend on severity as well as patient history, therefore, 
established guidelines should be followed to ensure treatments are chosen accordingly.  
 Currently, guidelines from the Centers for Disease Control and Prevention (CDC) as well 
as the Infectious Diseases Society of America (IDSA) provide structured treatment of SSTIs and 
are revised periodically based on epidemiological data, statistics, and the most up to date 
research. SSTIs continue to afflict individuals despite prevention campaigns. Protocols such as 
algorithms can help delineate the various treatment options in place and can assist providers in 
caring for these patients before infections become complicated. SSTIs are endemic amongst 
incarcerated populations; unfortunately, algorithms are seldom available for the health care 
providers to follow (David & Daum, 2010; Dellit et al., 2007; Dhar, 2018; Ellias, A.F., 
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Chaussee, M.S., McDowell, E.J., & Huntington, M.K., 2010; Federal Bureau of Prisons, 2012; 
Grief, 2017). 
Background and Significance 
 SSTIs include impetigo, cellulitis, folliculitis, carbuncles, abscesses, pyomyositis, orbital 
cellulitis, and necrotizing fasciitis (Popovich & Hota, 2008). Normal skin flora, including 
bacteria, are found on the superficial layers of the epidermis typically preventing pathogenic 
organisms from colonizing the skin (Aly, 1996); however, these organisms can become 
dangerous if they have an entry point into the body. The most common pathogens for skin 
infections are Staphylococcus and Streptococcus, with Methicillin-resistant Staphylococcus 
aureus (MRSA) being the most common pathogen causing skin infections in the United States 
(US), and account for over half of the community-associated SSTIs (Dhar, 2018).  
 The CDC estimate over 80,000 invasive MRSA infections with resultant 11, 285 deaths 
per year world-wide (CDC, 2014). In efforts to further track the number of MRSA infections, 
both international and national organizations have encouraged MRSA case tracking by including 
this in the National Healthcare Safety Network (NHSN) reportable disease category. In Arizona, 
the number of MRSA cases for 2017 was 1,357, which was almost 100 more than the previous 
year (Arizona Department of Health Services, 2018). There are factors which predispose 
individuals to develop SSTIs including: living in close quarters, previous skin infection, nasal 
colonization of MRSA, intravenous drug use, and previous infection (Grief, 2017; Liu et al., 
2008; Raff & Kroshinsky, 2016). Incarcerated individuals are at increased risk for SSTIs due to 
the presence of multiple risk factors simultaneously. These include any combination of the 
following: living in crowded cells/rooms, higher number of inmates having their anterior nares 
colonized with MRSA, personal history of SSTIs with subsequent exposure to antibiotics, not 
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finishing their treatment course due to becoming incarcerated, and being exposed to these 
organisms due to hospitalizations for other illness (Dober, 2014; Ellias, et al., 2010; Herman, 
R.A., Kee, V.R., & Moores, K.G., 2008; Lee et al, 2011).  
Problem Statement 
  The growing problem of SSTIs has surged due to the rising number of pathogens 
becoming resistant to established treatments. Multiple drug resistant organisms (MDROs) such 
as MRSA can be limited by the implementation of antibiotic stewardship programs, choosing the 
proper treatment for each infection per the recommended guideline and properly utilizing 
established tools, such as algorithms, for the treatment of infections for incarcerated individuals 
(Federal Bureau of Prisons, 2012; Stevens et al., 2014; Wlodaver & May, 2017). Current 
research demonstrates that a primary barrier for effective diagnosis and treatment of SSTIs is a 
lack of standardized tool use (Lee et. al., 2016; Mullen & O’keefe, 2015). 
 The incidence of SSTIs raise additional concerns with the incarcerated population. For 
example, incarcerated individuals often possess low levels of literacy which would make 
initiatives for the reduction of infection difficult to read and comprehend (Grief, 2017). Also, 
incarcerated patients pose an additional challenge to providers because of the inability to isolate 
patients with known infections due to the mandatory living conditions of shared cells and limited 
access to personal hygiene items. This in turn contributes to the spread of infections (Datta & 
Juthani-Mehta, 2017). Lastly, inmates face the challenge of obtaining appropriate health care due 
to only seeing providers once their condition is deemed urgent according to the nurses’ 
assessment which can delay the identification of SSTIs leading to rapid progression and 
increased complications, including death (Dober, 2014). 
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 A population-based study in San Francisco demonstrated that 85% of MRSA cases 
occurred outside a health care setting (Liu et al., 2008). A retrospective analysis of 986 hospitals 
in 33 states and 994 hospitals in 28 states concluded that bacteremia resulting from MRSA has 
increased mortality rate twice as high for inpatient treatment (Noskin et al., 2005). As a result, in 
the US, the CDC issued guidelines for the treatment of MRSA in October of 2006 (CDC, 2014). 
Despite availability of current guidelines for clinical practice, not all organizations housing at-
risk individuals have active policies or protocols which may help them determine an appropriate 
plan of care for new SSTIs. This is particularly true of jails and prisons, which house a large 
number of individuals that have frequent and/or recurrent SSTIs (David & Daum, 2010; Ellias, et 
al., 2010; Grief, 2017; Herman, R.A., Kee, V.R., & Moores, K.G.,2008).  
 There are similarities in the clinical presentation of skin infections and depending on staff 
knowledge and experience, there may also be limitations in the ability to adequately identify the 
causative organisms in a timely manner; delaying the diagnosis and treatment of SSTIs (Raff & 
Kroshinsky, 2016). High staff turn-around, lack of continuity of care due to rotating providers 
through various organizations, jail/prison restrictions related to limited content allowed within 
charts, length of time elapsed prior to being seen by providers, and limited pharmacological 
agents available for in-house treatment pose barriers to implementation of algorithms for 
treatment of SSTIs for incarcerated populations. 
 Careful assessment of incarcerated population risk factors can lead to prompt 
identification of SSTIs based on degree of severity during the provider’s initial history taking 
and physical examination (Chahine & Sucher, 2015). Provider ordered daily wound care can be 
utilized to track the improvement of a SSTI and can also help decrease complications. One such 
outcome which would show improvement in the treatment of SSTIs in this population would be 
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the reduction of infections requiring incision and drainage (I&D) treatment, which is usually 
reserved for complicated cases (Raff & Kroshinsky, 2016). Another complication of under-
treated SSTIs is treatment failure, characterized by no improvement seen after finished course of 
antibiotics. Treatment failure can be identified by enlarged area of erythema, increased purulence 
production, and systemic symptoms. If treatment failure occurs, the provider can decide on the 
necessary course of action to ensure the SSTI is successfully treated, even if it requires inpatient 
hospital treatment (Labreche et al., 2013; Noskin et al., 2005; Wlodaver & May, 2017). These 
complications have been shown to be reduced by antimicrobial stewardship programs and may 
be further improved through implementation of interventions that will allow for the following of 
algorithms as they will decrease the number of inappropriate antibiotic treatments (Carrerra, E., 
Pfeffer, I., Zusman, O, Leibovici, L, & Paul, M., 2017; Dellit et al., 2007).  
 One of five patients experience treatment failure and will likely require additional 
interventions at an associated cost of almost $2,000 per patient (Labreche et al., 2013). This does 
not include the costs unique to a correctional facility as it relates to prolonged in-house 
treatment, staff who must accompany an inmate for off-site treatment, transportation, and any 
potential hospital costs for inpatient care, supplies, and medications; expenses which are the 
responsibility of correctional health services. An additional cost can also be accrued if the patient 
presents with new areas of infection as a result of spreading the infection to other parts of the 
body. With early identification and prompt treatment, these costs can all be reduced.  
 In a correctional facility in the Southwestern US, an SSTI algorithm was recently 
instituted to facilitate the early identification and prompt treatment of these type of infections due 
to their frequent presentation. Despite a successful presentation to the providers at mandatory 
staff meetings, there were several barriers identified which may interfere with the algorithm 
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being utilized optimally. One barrier identified was that not all current providers were present 
during the presentation. In an effort to further promote the use of the algorithm amongst current 
health care providers, the question that must be answered is how to disperse the tool to all new 
and rotating staff members. Additionally, patient perspective should be taken into account in 
regard to anticipated outcomes vs cost of treatment. In this facility, inmates pay $5 for a nursing 
visit, $10 for healthcare provider visit, and $5 per medication ordered. While this may not appear 
to be a significant cost, inmates receive no income, may or may not receive money from family, 
and must choose between paying for health care costs or buying personal items they might need 
from detention services. If providers encounter barriers to implementing current guidelines, the 
treatment may be extended and the outcomes may be compromised due to the high prevalence of 
MDROs (Carrara et al., 2017). The promotion of current recommendations, including tools such 
as algorithms may amplify the implementation of best practices and is key in curtailing the 
effects of SSTIs (CDC, 2011), specifically in the incarcerated population. 
 Absent or inconsistent use of existing tools for the diagnosis and treatment of these types 
infections has led to the clinically relevant question: when treating incarcerated adults, does 
placing a copy of a pre-existing algorithm in each exam room improve the rate of utilization of 
the algorithm for providers for treating individuals with a SSTI diagnosis over a two-week 
period? 
Search Strategy 
 In an attempt to establish the current use of algorithms in correctional facilities for the 
treatment of SSTIs, an exhaustive search was performed. Literature review was performed after 
the following databases were searched: Elton B Stephens Company host (EBSCO host), 
PubMed, PsycINFO, and the Cochrane Library. The keywords utilized were “protocol”, “clinical 
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judgement”, “skin infections”, “jails”, and “prisons”. There were limits utilized which included 
adult population, systematic reviews, meta-analysis, randomized control trials, and publications 
within the last five years. Initially, some searches were yielding no results, so it was decided to 
include Boolean phrases and MESH terms that may increase the yield. These terms included 
“correctional facilities”, “institutions”, “algorithms”, and “improved outcomes”. Inclusion 
criteria for the studies included those with adult populations, populations living in close contact, 
and those with established protocols/guidelines for treatments provided to this population. 
Exclusion criteria included: studies greater than ten years old and population less than eighteen 
years old. The Boolean phrase term search on EBSCO host yielded 523 results (Appendix A). 
The search was refined to include “improved outcomes” and “guidelines” and thus yielded a 
final 17 studies. 
 The MESH terms method used for PubMed found 15,629 articles (Appendix B). It was 
then decided to change the order of the terms and to filter based on type of article published to 
reviews, clinical trials, and meta-analysis. This narrowed the findings to 822 and was furthered 
refined by choosing the title/abstract as the location for the keywords which resulted in a 
manageable 28.  
 The search done in PsycINFO which included the keyword “algorithm” resulted in 1,134 
findings (Appendix C). It was decided to replace this term with “clinical judgement” as this 
portion of the topic still needed to be addressed. This reduced the number of publications to 453 
and limits on type of publication and year of publication were added which produced a 
manageable result of ten. 
 Performing a search within the Cochrane Library was different than the other databases. 
In order to obtain any results, the filters were set to include studies within the last 20 years and 
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the keywords utilized were limited to “jail”, “protocol”, and “inmates”. The results were only 
twelve (Appendix D). The final analysis included 10 publications that were selected based on 
their relevance and high level of statistical significance to the topic at hand.  
Evidence Synthesis 
 A total of ten studies were selected for the literature review. Following evaluation 
utilizing the rapid critical appraisal method, data was extracted, summarized, and placed in an 
evaluation (Appendix E) and synthesis table (Appendix F). The strength of the studies was 
moderate as it included publications of all levels of evidence including: two level I, three level II, 
three level III, and two level IV (Melnyk & Fineout-Overholt, 2015). The studies included two 
systematic reviews, two retrospective cohort studies, one randomized control trial, three 
observational studies with chart review, and one quality improvement project (Appendix F). 
 Although settings outside of correctional health were utilized, it was due to the lack of 
studies performed in this particular setting. Alternate settings were selected due to their inclusion 
of prisoners, which allowed to study this specific population. Of the studies, few cited theoretical 
frameworks or models, but the ones that did predominantly chose the Multifactorial Causation 
Theory or the Levels of Prevention Model. Each publication was chosen due to the discussion, 
inclusion, or relevance it had in relation to incarcerated populations. Less than half of the articles 
utilized measuring instruments with associated specificities or sensitivities (Appendix E), which 
was expected as none of them discussed an accepted protocol/algorithm utilized for the 
incarcerated population.  
 Four of the articles did utilize reliable and valid tools to help demonstrate the statistical 
significance of utilizing established tools in the treatment of this population (Appendix E). 
Possible bias was noted in two studies, one whose author was employed the funding company 
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and another who was reimbursed for each patient they enrolled in the study. However, upon 
further research, it was noted that the studies in question did not support use of specific 
medications, instead, they both highlighted the importance of proper identification of infections 
in order to reduce length of treatment and cost per patient (Appendix E). The studies which took 
place in hospitals focused on the difference between treating as an outpatient versus treatment 
failure as a result of inadequate antibiotic therapy leading to hospitalization. The majority of the 
studies took place in the US, increasing the generalizability of the findings to the population of 
interest since the percentage of incarcerated individuals in the US has increased by 300% since 
1980 (Mullen, L. A. & O’keefe, C., 2015).  
 The sample population focused on incarcerated adults or those with similar 
demographics, with a definite inclusion limited to adults greater than 18 years old. The majority 
of the studies highlighted the positive outcomes associated with ensuring timely antibiotic 
treatment through the use of following established guidelines. As a whole, the studies discussed 
challenges that may be present while prescribing medications within correctional facilities, while 
three focused on the implementation of antibiotic stewardship programs (Appendix E). Overall, 
the study findings established the importance of appropriate antibiotic therapy when treating 
infections in incarcerated populations related to overall cost savings and decreased 
complications.  
 Despite available treatment guidelines and the current number of SSTIs worldwide, in 
2016, the CDC released a list of organisms which pose even greater threats to public health in an 
attempt to highlight the importance of multi-drug resistant organisms (MDROs) worldwide 
(CDC, 2014). The facts include both the number of cases reported of the most common MDROs 
as well as the number of deaths which are a direct result of these organisms (CDC, 2014). The 
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CDC supports preventive efforts, prompt recognition, and aggressive treatments of infections 
with a main goal of reduction in mortality. Similarly, the ISDA strives to update guidelines for 
the treatment of SSTIs periodically due to the prevalence of MDROs and limited number of 
antibiotics which have been found to successfully eradicate these organisms (Stevens et al., 
2014). These guidelines acknowledge the necessity and efficacy of different treatment options 
and support them according to the severity of the infection. To best disburse these guidelines, 
algorithms are put in place to ensure the same process is being followed by all providers within a 
health care organization. An effective approach would include having the algorithm readily 
available for providers to reference during each face-to-face encounter and utilizing it for 
deciding treatment for every infection (Hashem, N. G., Hidayat, L., Berkowitz, L., & 
Venugopalan, V., 2016). 
Purpose Statement 
 An evidence-based project was designed to increase the accessibility of an algorithm for 
the treatment of SSTIs in a correctional facility in the Southwestern United States in order to 
increase adherence to treatment guidelines for SSTIs. The change to current practice will be 
incorporating the tool into each patient-provider visit by placing a copy in the exam rooms in an 
attempt to increase its use and thus improve the outcomes of prisoners with a SSTIs diagnosis. 
Quality Improvement Model 
 The Model for Improvement Plan, Do, Study, Act (PDSA) will enable the change to 
current clinical practice. This model is utilized in health care as a step driven guide to improve 
current practices.  It begins by analyzing the current practice and coming up with a proposed 
plan to change it. The next step is implementing the plan and gathering the data to be able to 
demonstrate the change was implemented. After a pre-determined time has passed the data 
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would be reviewed, summarized, and evaluated to ensure no changes are necessary (Langley et 
al., 2009). Following this model would facilitate the implementation of a project within a large 
organization as it allows for evaluation and critique of current practices with subsequent analysis 
of any barriers which may arise before actually implementing the proposed project. Also, the 
PDSA is appropriate to use within different facilities as there may be organizational changes 
specific to different environments that may not be foreseen but can be addressed after the project 
is implemented. The cyclical nature of this model allows for any necessary modifications to be 
made if the results of the project are inconsistent with expected results and can allow the 
organization to pinpoint what step needs to be changed (Appendix H).  
Conceptual Framework 
 Increasing the use of an established algorithm within correctional facilities would require 
three factors to be considered: the setting, the health care providers, and the treatment being 
provided. The Social Cognitive theory underpins this project as it focuses on environment, 
people, and behavior (Bandura, 2001). This theory supports the idea that these three factors are 
constantly influencing one another and they cannot be independent of each other (Appendix G). 
Additionally, it supports that the capability of an individual to endorse a particular behavior with 
the assumption that they have been given the proper information and possess the knowledge to 
perform it adequately. Hence, it would translate into clinical practice by requiring health care 
providers to understand, acknowledge, and implement the algorithm for each patient presenting 
with a SSTI. This theory would further support a practice change by promoting learning through 
the observation of others. Therefore, even in an environment where there are multiple providers 
caring for the same patients, following the algorithm would be more likely if providers have 
access to the same tool for each encounter. Thus, the logic of altering the environment of the 
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visits would increase the provider use of the algorithm and subsequently improve the treatment 
of prisoners with SSTIs.  
Project Methods 
 The project was drafted, submitted, and received IRB approval by Arizona State 
University as well as support by the facility medical director. The setting for the project was a 
correctional facility in the Southwestern United States which houses more than 2,300 prisoners 
on a daily basis. This facility was selected as it was part of a larger organization which had an 
algorithm developed previously to assist their providers in selecting appropriate treatments for 
SSTIs. Despite a receptive attitude amongst the medical director, providers, nurses, and ancillary 
staff of the algorithm, it was discovered the use of the algorithm was not being monitored and the 
rate of turnover was very high which appeared to be limiting the use of the algorithm.  
 The project coordinator determined providers were the frontline when implementing the 
algorithm correctly and as such they were recruited to participate in the project. A survey was 
developed by the project coordinator which would anonymously gather demographic 
information, determine whether the providers had knowledge of the existence of the algorithm, 
utilize a Likert scale for providers to rate their current use of the algorithm, and to ask providers 
what they felt were the current barriers to using the algorithm. In order to secure their 
participation, they were assured that their responses to the survey would be anonymous and 
tracked with 4-digit identification numbers that only the project coordinator would have access 
to. Consent was implied via completion of the survey by providers, thus, this part of the project 
consisted of hand-delivering the surveys. The providers were allotted enough time for 
completion and after the information was tabulated, it was determined that the main barrier for 
utilization consisted of a lack of accessibility.  
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 From there, the intervention of placing the algorithm into the electronic medical record 
was decided. However, due to financial limitations, this option was not feasible. A modification 
was made to the initial plan by choosing a more affordable option: making full-size, laminated 
copies of the algorithms and placing directly in all exam rooms for providers to have available 
for each face-to-face encounter. This proved to be a better option for this facility as the budget to 
implement the project consisted of spending a mere $20 US dollars.  
 In order to determine utilization of the algorithm, it was necessary to perform a 
retrospective chart analysis. Prisoner charts were reviewed over a 2-week period pre and post 
intervention to identify those who had a SSTIs diagnosis. Each prisoner chart was given a five-
digit identification number on a spreadsheet which was used to keep the necessary data and had 
no patient identifiers linked to the original charts. To effectively qualify as having used the 
algorithm, the provider had to include the following components: adequate diagnosis, proper 
antibiotic selection, and if indicated, wound care orders. Measurement outcomes were obtained 
by giving each prisoners’ chart a subject number without including any individual identifiers. 
After the data was validated, it was coded and both the survey and chart review results were 
analyzed utilizing SPSS version 25. Comparing the pre and post intervention rate of utilization 
was done by calculating the number of cases of SSTIs that were properly treated with the 
algorithm in each 2-week period before and after the intervention. A tally was also kept of the 
total number of SSTIs diagnosed for the duration of the project.  
Outcomes/Project Results/Impact 
 Provider participation only yielded eight participants. Their ages ranged from 29-57 years 
old with four identifing as females and four as males. Amongst them, one was a physician, two 
were nurse practitioners, and five were physician assistants. Of the eight providers, only three 
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reported having knowledge of the existence of the algorithm prior to the intervention and even 
then, only two of them reported using it “sometimes” for the treatment of SSTIs. Overall, the 
provider responses indicated that if they could see the algorithm during visits, they would use it 
more often. After the intervention, the same providers were surveyed and seven of the eight 
endorsed the algorithm as a tool they used “frequently” when treating SSTIs.   
 The total number of charts reviewed was 97. For statistical analysis, the Pearson Chi 
Square two-tailed test was utilized as it is suitable for unpaired data sets when testing a null 
hypothesis, with p< 0.05 indicating significance. If the p-value is larger than the significance 
level, you fail to reject the null hypothesis because there is not enough evidence to conclude that 
the variables are associated (Keller & Kelvin, 2013). The results were calculated via SPSS 
version 25 and yielded p= 0.137, showing non-significance.  
 Prior to intervention, there were 55 SSTIs diagnosed, 18 of which met algorithm criteria; 
therefore, the rate of utilization was 32.7%. For the post intervention period, there were 42 SSTIs 
diagnosed with 20 meeting algorithm criteria. This showed an increase of 14.9% use of the 
algorithm amongst all providers. This was clinically significant because it correlated with the 
provider responses post-intervention of increased use of the algorithm. 
 Additionally, it was noted that there was a 23% decrease in total number of SSTIs 
diagnosed during the post intervention period. This was clinically significant as it could be 
related to adequate initial treatment leading to a decrease in number of treatment failures 
(Carrera et al., 2017; Kamath, et al., 2018; Labreche et al., 2013; Lane et al., 2016).  
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Discussion 
 Demonstrating the positive effects of utilizing algorithms for the treatment of SSTIs can 
promote a change to the current practice within correctional facilities. The change to current 
practice will ensure correctional health care providers are following the most current guidelines 
when treating SSTIs which will be supported with a marked reduction in treatment time, 
decrease in complications, and decreased costs. These benefits will positively impact the 
prisoners, the providers, and the correctional facilities who choose to implement this change. 
This project intervention has minimal costs when compared to the long-term savings that will be 
seen by the facilities and organizations who do not currently follow the practice of utilizing 
algorithms in the treatment of SSTIs.  
 Limitations of this project consisted of small sample sizes and short intervention period, 
both can be explained by the setting of the project and the amount of time it takes to receive IRB 
approval in these types of facilities. Future studies should be done in larger facilities, over a 
longer period of time, and be based on the most up-to-date guidelines.  Sustainability of the 
project would consist of monitoring for any updates made to current recommendations in the 
treatment of SSTIs and then changing the algorithm accordingly. These updates are only 
necessary every couple of years, when the CDC or IDSA release their new guidelines, and this 
can be delegated to the education coordinator of each facility which minimizes the costs and 
maximizes its savings. The algorithm will be presented to all providers during the on-boarding 
process to ensure they are educated about its existence and availability. 
Conclusions 
 Despite current treatment guidelines in regard to SSTIs in the general population, there 
exists no established protocol for implementation of these guidelines for special populations such 
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as those in correctional facilities. The studies suggest a need for providers to be consistent when 
treating infections, particularly when it involves resistant pathogens due to the complexity of 
their treatment. The research does not discuss whether the guidelines from one organization 
would be better than another, it simply supports that utilizing guidelines is recommended as it 
decreases the risk of complications and promotes improved outcomes. The research reviewed 
indicates that health care providers working in correctional facilities should implement SSTI 
treatment guidelines using a standard approach, which can easily be done when following a pre-
established algorithm. If the implementation of algorithms continues to be promoted and results 
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 Table 2 
 Synthesis Table 
Study 
Characteristics 
Carrara Drobniewski Hashem Hassan Kamath, J. Kamath, R.S. Labreche Lane Mullen Talan 
Year 2017 2015 2016 2016 2013 2018 2013 2016 2015 2014 
LOE I I III IV II III II II IV III 
Conflict/bias None None None Yes None None Yes Yes None None 
Location Israel UK US UK US US US UK US US 
Design SR SR Retro CS Obs Int RCT Retro 
analysis 
Obs study Obs C-SS QIP Retro CS 
N  73,595 56 200 17 40 240 265 400 132 619 
Setting Other Other  community 
hospital 











x      x  x  
Severity tool   x        
algorithm  x   X      
Follow 
guidelines 
   x  x  x  x 
Outcomes            
IEAT x  x   x   x  
TXF x   x  x x x x x 
INPT   x  x x x x  x 
OTPT   x  x x x x  x 
I&D x     x     
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